“DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS”. International Journal of Artificial Intelligence, vol. 5, no. 09, Sept. 2025, pp. 221-3, https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299.